On average, they are down 8.3% since the latest earnings results. Revolutionizing diabetes care with its tubeless "Pod" ...

Click here to discover the nuances of Insulet with our detailed analytical report. NasdaqGS:PODD Revenue & Expenses Breakdown as at Mar 2025 Insulet (NasdaqGS:PODD) has rewarded its shareholders ...

Wall Street analysts expect Insulet (PODD) to post quarterly earnings of $1.05 per share in its upcoming report, which indicates a year-over-year decline of 25%. Revenues are expected to be $581. ...